Open AccessTargeting KEAP1-Mutant NSCLC With Broad-Acting Glutamine Antagonist
Author(s) -
Thales Papagiannakopoulos
Publication year - 2022
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000852788.30446.d7
Subject(s) - druggability , cancer research , lung cancer , cancer , medicine , keap1 , adenocarcinoma , mutant , glutamine , oncology , biology , gene , genetics , transcription factor , amino acid